NeoGenomics Laboratories, Inc. (NEO)VA awarded $2.79M

$2.79M

committed so far

Signed

Oct 10, 2025

Updated

Oct 10, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 10, 2025 · this disclosureFederal contract · $2.8M obligatedDepartment of Veterans Affairs awarded NEOGENOMICS INC: $2.79M obligated to date

What came next

1. Oct 23, 2025Federal contract · $325K obligatedDepartment of Veterans Affairs awarded NEOGENOMICS INC: $325K obligated to date
2. Oct 28, 2025Company filing · Form 8-K · ResultsReported its results
3. Dec 23, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 23, 2025, the Board of Directors (the "Board") of NeoGenomics, Inc. (the "Company") accepted the resignation of Dr. Alison L. Hannah as a director of the Company effective December 31, 2025.”
4. Jan 9, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results“On January 12, 2026, the Company announced that, on January 9, 2026, Jeffrey S. Sherman, the Company’s Chief Financial Officer, notified the Board of Directors of the Company (the "Board") of his intention to retire.”
5. Feb 4, 2026Federal contract · $500K obligatedDepartment of Veterans Affairs awarded NEOGENOMICS INC: $500K obligated to date

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for NeoGenomics Laboratories, Inc.

For NeoGenomics Laboratories, Inc., OQRO holds 1 Congress trade report and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its NEO page.

How this filing works

• Contract ceiling vs obligated amount

Other disclosures at NeoGenomics Laboratories, Inc.

• House Clerk periodic transaction reportSep 10, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRAug 14, 2026
• USAspending.gov award recordJun 17, 2026
• USAspending.gov award recordJun 11, 2026
• SEC Form 13F-HRMay 22, 2026

Everything OQRO holds on this company is on its NEO page.